Skip to content

Routine care and monitoring

How your doctor will manage your condition using current clinical practice guidelines

Routine checks in PSC (Dr James Ferguson)

PSC is a complex condition and ideally, your care should be managed by someone with an interest in and experience of PSC. While there is no curative treatment, your doctor can monitor your condition and help manage your symptoms using current clinical practice guidelines for cholestatic liver diseases.

Because of the serious nature of the complications of PSC, you should remain under lifelong follow up with your PSC doctor (BSG/UK-PSC Guidelines Recommendation 4 58).

If you start to get more symptoms and your PSC is evolving or becoming complex, you should be referred for expert multi-disciplinary assessment. Patients with early, stable disease can be managed in general clinics (BSG/UK-PSC Guidelines Recommendation 16 58).

Your doctor will also discuss with you how he or she will manage your routine PSC healthcare and together you will form a PSC care plan and communicate this to your GP. Your GP should not be expected to know everything about PSC, and therefore it is helpful when your Hepatology/Gastroenterology consultant shares a clear picture of how you will be monitored and what role your GP will play.

Your PSC doctor will also give you information about what to do about concerns and how to contact the clinic.

Routine Care and Monitoring

Once PSC is diagnosed, your doctor will discuss with you and assess the following:

Cancer risk

Osteoporosis assessment (bone density)

Symptoms (such as itch, pain and fatigue)

Malabsorption of fat-soluble vitamins (in the case of more advanced PSC)

IBD screening

Clinical trials eligibility

Liver and bile ducts (extent of damage)

Related News

Use Your Voice to Shape the Future of Liver Transplant Allocation

01 Apr 2025

As the only UK patient organisation dedicated to improving the lives of people affected by PSC we know how important it is for your voices to be heard. That’s why we’re sharing an opportunity for you to have your say in the current review of the National Liver Offering Scheme (NLOS).

Representing PSC Patients at the ERN RARE-LIVER Annual Meeting

01 Feb 2025

Martine Walmsley, PSC Support Head of Research Strategy, represented patients with rare liver diseases at the ERN RARE-LIVER annual meeting.

Breaking News from ICR

30 Jan 2025

Researchers at the Institute of Cancer Research (ICR) and St Mark’s Hospital in London have shared news today that they have developed a test to predict bowel cancer risk in people with inflammatory bowel disease.

First Participant in FARGO Trial

24 Jul 2024

A PSC Support Trustee has been diagnosed with both PSC and inflammatory bowel disease (IBD). They is receiving weekly poo transplants to treat the conditions in a world first trial.

Important Patient Survey

17 May 2024

Have you ever had a cholangitis attack? If so, please take this important survey today.

Quality of Your PSC Care

13 Jul 2023

ERN RARE-LIVER survey results have been published. Thank you to the 939 people with PSC who took part in this survey.

Managing Your Care

30 Mar 2023

Tips from Dr Andrew Yeoman on managing your healthcare at a time when our healthcare services are under increasing pressure to meet demands.

PSC Support Vancomycin Statement

30 Nov 2022

Statement from PSC Support about the use of vancomycin in the UK.

New European Guidelines for the care of People with PSC

30 Nov 2022

A summary of the latest PSC care guidelines for Europe.

Ask the Expert Live Q&A with Dr Deepak Joshi 14 January 2023

10 Nov 2022

Join us on 14 January 2023 for a live Q&A on all things PSc with Dr Deepak Joshi

Make a difference

Donate today

Friend or family?

12 things you you need to know about PSC

What we do

Improving the lives of people affected by PSC